Modern methods of intraoperative fluorescent imaging of the parathyroid glands in endocrine surgery: a literary review

Biomedical Photonics, 2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.24931/2413-9432-2025-14-1-47-52
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Hyperparathyroidism (primary, secondary and tertiary) is a common endocrine disease, often occurring with pronounced symptoms, in most cases caused by adenoma (rarely several adenomas) in primary hyperparathyroidism (pHPT) and chronic renal failure in patients on programmed hemodialysis with secondary (sHPT) and tertiary (tHPT) hyperparathyroidism. To date, the only radical treatment for hyperparathyroidism (HPT) is surgical removal of pathologically altered parathyroid glands. In this regard, there is a need to improve diagnostic search algorithms, including intraoperative ones, for altered parathyroid glands. The main objective of the review is to study current trends and techniques of intraoperative imaging of the parathyroid glands, compare these methods and evaluate their effectiveness. The use of qualitatively new technologies for the topical diagnosis of altered parathyroid glands, such as identification by autofluorescence in the near infrared spectrum (NIRAF), the technique of using indocyanine green (ICG) and 5-aminolevulinic acid under UV radiation, make it possible to visualize the localization of the parathyroid glands with more than 90% accuracy. However, the issue of their priority use remains open and unresolved.